MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders
- 1 August 1998
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 102 (3) , 710-717
- https://doi.org/10.1046/j.1365-2141.1998.00822.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The detection of rhodamine 123 efflux at low levels of drug resistanceBritish Journal of Haematology, 1996
- Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometryCytometry, 1995
- High mdrl- and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukaemiasCancer Letters, 1994
- The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.Proceedings of the National Academy of Sciences, 1994
- Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysisLeukemia Research, 1994
- MDR1 Gene Expression in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1994
- Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistanceLeukemia Research, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- Isolation and expression of a complementary DNA that confers multidrug resistanceNature, 1986